$ZPTA
Zapata Computing Holdings Inc.

2023 Q4 Form 10-K Financial Statement

#000119312524076744 Filed on March 26, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $1.329M $5.683M
YoY Change
Cost Of Revenue $904.0K $4.582M
YoY Change 29.62%
Gross Profit $425.0K $1.101M
YoY Change -32.5%
Gross Profit Margin 31.98% 19.37%
Selling, General & Admin $3.633M $13.29M
YoY Change -20.93%
% of Gross Profit 854.82% 1207.45%
Research & Development $821.0K $5.915M
YoY Change -27.92%
% of Gross Profit 193.18% 537.24%
Depreciation & Amortization $34.00K $164.0K
YoY Change -6.82%
% of Gross Profit 8.0% 14.9%
Operating Expenses $4.454M $19.21M
YoY Change 859.31% 1172.58%
Operating Profit -$4.029M -$8.349M
YoY Change 453.15%
Interest Expense -$40.00K $70.92K
YoY Change -102.01% -97.91%
% of Operating Profit
Other Income/Expense, Net -$3.671M $7.487M
YoY Change 120.21%
Pretax Income -$14.60M -$29.71M
YoY Change -1054.5% -1671.93%
Income Tax -$9.000K $0.00
% Of Pretax Income
Net Earnings -$14.60M -$862.9K
YoY Change -1053.91% -145.65%
Net Earnings / Revenue -1098.19% -15.18%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.50 -$1.02
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.332M $3.332M
YoY Change 440.8% 440.8%
Cash & Equivalents $0.00 $3.332M
Short-Term Investments
Other Short-Term Assets $323.0K $323.0K
YoY Change -45.34% -45.34%
Inventory
Prepaid Expenses
Receivables $1.938M $1.938M
Other Receivables $0.00 $0.00
Total Short-Term Assets $205.5K $5.593M
YoY Change -82.97% 363.38%
LONG-TERM ASSETS
Property, Plant & Equipment $156.0K $394.0K
YoY Change -56.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $137.0K $2.080M
YoY Change 459.87% 8400.2%
Total Long-Term Assets $86.27M $2.474M
YoY Change -63.93% -98.97%
TOTAL ASSETS
Total Short-Term Assets $205.5K $5.593M
Total Long-Term Assets $86.27M $2.474M
Total Assets $86.47M $8.067M
YoY Change -64.03% -96.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.452M $6.452M
YoY Change 354.05%
Accrued Expenses $1.892M $1.892M
YoY Change 6134.35% 1540.23%
Deferred Revenue $744.0K
YoY Change 48.8%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $955.8K $9.393M
YoY Change 728.66% 8043.04%
LONG-TERM LIABILITIES
Long-Term Debt $8.900M $8.900M
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $8.900M $8.900M
YoY Change 8.4% 8.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $955.8K $9.393M
Total Long-Term Liabilities $8.900M $8.900M
Total Liabilities $15.50M $18.29M
YoY Change 86.13% 119.73%
SHAREHOLDERS EQUITY
Retained Earnings -$15.29M
YoY Change 115.53%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.29M -$10.23M
YoY Change
Total Liabilities & Shareholders Equity $86.47M $8.067M
YoY Change -64.03% -96.64%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$14.60M -$862.9K
YoY Change -1053.91% -145.65%
Depreciation, Depletion And Amortization $34.00K $164.0K
YoY Change -6.82%
Cash From Operating Activities -$2.378M -$3.044M
YoY Change 1142.03% 57.52%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $161.0M
YoY Change -168.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $161.0M
YoY Change 2588573.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.389M -158.5M
YoY Change -166.49%
NET CHANGE
Cash From Operating Activities -2.378M -3.044M
Cash From Investing Activities 0.000 161.0M
Cash From Financing Activities 2.389M -158.5M
Net Change In Cash 11.00K -454.9K
YoY Change -105.75% -173.83%
FREE CASH FLOW
Cash From Operating Activities -$2.378M -$3.044M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.378M -$3.044M
YoY Change 39.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001843714
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41218
CY2023 dei Entity Registrant Name
EntityRegistrantName
ANDRETTI ACQUISITION CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578373
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
7615 Zionsville Road
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Indianapolis
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46268
CY2023 dei City Area Code
CityAreaCode
317
CY2023 dei Local Phone Number
LocalPhoneNumber
872-2700
CY2023 dei Security12b Title
Security12bTitle
Class A ordinary shares, $0.0001 par value
CY2023 dei Trading Symbol
TradingSymbol
WNNR
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
244720000
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, CA
CY2023 wnnr Number Of Days Within Which The Public Shares Shall Be Redeemed
NumberOfDaysWithinWhichThePublicSharesShallBeRedeemed
P10D
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.andrettiacquisition.com/20231231#ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Net Derivative Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://www.andrettiacquisition.com/20231231#ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Cash
Cash
161224
CY2022Q4 us-gaap Cash
Cash
616120
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44304
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590883
CY2023Q4 us-gaap Assets Current
AssetsCurrent
205528
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1207003
CY2023Q4 wnnr Prepaid Insurance Non Current
PrepaidInsuranceNonCurrent
0
CY2022Q4 wnnr Prepaid Insurance Non Current
PrepaidInsuranceNonCurrent
24469
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
86265079
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
239149736
CY2023Q4 us-gaap Assets
Assets
86470607
CY2022Q4 us-gaap Assets
Assets
240381208
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
884928
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
30348
CY2023Q4 wnnr Accrued Interest Payable Related Party Current
AccruedInterestPayableRelatedPartyCurrent
70918
CY2022Q4 wnnr Accrued Interest Payable Related Party Current
AccruedInterestPayableRelatedPartyCurrent
0
CY2023Q4 wnnr Accrued Offering Costs Current
AccruedOfferingCostsCurrent
0
CY2022Q4 wnnr Accrued Offering Costs Current
AccruedOfferingCostsCurrent
85000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
955846
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115348
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2450083
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2023Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
4040000
CY2022Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
160000
CY2023Q4 wnnr Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
8050000
CY2022Q4 wnnr Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
8050000
CY2023Q4 us-gaap Liabilities
Liabilities
15495929
CY2022Q4 us-gaap Liabilities
Liabilities
8325348
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
86265079
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
239149736
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15290976
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7094451
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-15290401
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7093876
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86470607
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
240381208
CY2023 wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
8349476
CY2022 wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
1509446
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-8349476
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1509446
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
8156697
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3399736
CY2023 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
599222
CY2022 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
0
CY2023 us-gaap Interest Expense
InterestExpense
70918
CY2022 us-gaap Interest Expense
InterestExpense
0
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7486557
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3399736
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-862919
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1890290
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14139
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13550000
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6440000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10409031
CY2022 wnnr Transaction Costs Allocated To Fair Value Equity Instruments
TransactionCostsAllocatedToFairValueEquityInstruments
-707430
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
38689906
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1890290
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7093876
CY2023 wnnr Proceeds Receivedin Excess Offair Value Of Convertible Promissory Notes
ProceedsReceivedinExcessOffairValueOfConvertiblePromissoryNotes
823091
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
8156697
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-862919
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-15290401
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-862919
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1890290
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
8156697
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3399736
CY2023 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
599222
CY2022 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
0
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-546579
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
588834
CY2023 wnnr Increase Decrease In Prepaid Insurance Non Current
IncreaseDecreaseInPrepaidInsuranceNonCurrent
-24469
CY2022 wnnr Increase Decrease In Prepaid Insurance Non Current
IncreaseDecreaseInPrepaidInsuranceNonCurrent
24469
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
854580
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30348
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
70918
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2023 wnnr Increase Decrease In Deferred Legal Fee Payable
IncreaseDecreaseInDeferredLegalFeePayable
3880000
CY2022 wnnr Increase Decrease In Deferred Legal Fee Payable
IncreaseDecreaseInDeferredLegalFeePayable
160000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3043848
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1932401
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
235750000
CY2023 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
161041354
CY2022 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
-235750000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
161041354
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-235750000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6221
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
225400000
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
13550000
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
75
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
240629
CY2023 wnnr Proceeds From Convertible Promissory Notes Related Party
ProceedsFromConvertiblePromissoryNotesRelatedParty
2673952
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
161041354
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
417146
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158452402
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
238298521
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-454896
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
616120
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
616120
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161224
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
616120
CY2023 wnnr Remeasurement Of Class A Ordinary Shares Redemption Amount
RemeasurementOfClassAOrdinarySharesRedemptionAmount
8156697
CY2022 wnnr Remeasurement Of Class A Ordinary Shares Redemption Amount
RemeasurementOfClassAOrdinarySharesRedemptionAmount
35290170
CY2023 wnnr Proceeds Received From Convertible Promissory Notesin Excess Ofinitial Fair Value
ProceedsReceivedFromConvertiblePromissoryNotesinExcessOfinitialFairValue
823091
CY2022 wnnr Proceeds Received From Convertible Promissory Notesin Excess Ofinitial Fair Value
ProceedsReceivedFromConvertiblePromissoryNotesinExcessOfinitialFairValue
0
CY2023 wnnr Offering Costs Included In Accounts Payable Accrued Expenses
OfferingCostsIncludedInAccountsPayableAccruedExpenses
0
CY2022 wnnr Offering Costs Included In Accounts Payable Accrued Expenses
OfferingCostsIncludedInAccountsPayableAccruedExpenses
85000
CY2023 wnnr Fair Value Of Founder Shares In Excess Attributable To Anchor Investor
FairValueOfFounderSharesInExcessAttributableToAnchorInvestor
0
CY2022 wnnr Fair Value Of Founder Shares In Excess Attributable To Anchor Investor
FairValueOfFounderSharesInExcessAttributableToAnchorInvestor
10402810
CY2023 wnnr Accretion Of Classa Shares To Redemption Value
AccretionOfClassaSharesToRedemptionValue
0
CY2022 wnnr Accretion Of Classa Shares To Redemption Value
AccretionOfClassaSharesToRedemptionValue
3399736
CY2023 wnnr Deferred Under Writing Fees Payable
DeferredUnderWritingFeesPayable
0
CY2022 wnnr Deferred Under Writing Fees Payable
DeferredUnderWritingFeesPayable
8050000
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-20
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.25
CY2023Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q4 wnnr Percentage Of Public Shares That Can Be Transferred Without Any Restriction
PercentageOfPublicSharesThatCanBeTransferredWithoutAnyRestriction
0.15
CY2023Q4 wnnr Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2023 wnnr Period From The Closing Of The Initial Public Offering Within Which Business Combination Shall Be Completed
PeriodFromTheClosingOfTheInitialPublicOfferingWithinWhichBusinessCombinationShallBeCompleted
P18M
CY2023Q4 wnnr Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2023Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
15105199
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
84200000
CY2023Q3 wnnr Stock Redemption Price Per Share
StockRedemptionPricePerShare
10.66
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.25
CY2023Q4 us-gaap Cash
Cash
161224
CY2023Q4 wnnr Working Capital
WorkingCapital
750318
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </div>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
15105199
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
84200000
CY2023Q3 wnnr Stock Redemption Price Per Share
StockRedemptionPricePerShare
10.66
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company had not experienced losses on this account. </div>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 wnnr Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
240629
CY2023Q4 wnnr Cummulative Cash Advanced
CummulativeCashAdvanced
2673952
CY2023Q4 wnnr Deferred Underwriting Commission Payable Per Share
DeferredUnderwritingCommissionPayablePerShare
0.35
CY2023Q4 wnnr Deferred Underwriting Commission Payable Current
DeferredUnderwritingCommissionPayableCurrent
8050000
CY2023Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
4040000
CY2022Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
160000
CY2023Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
15105199
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
84200000
CY2023Q3 wnnr Stock Redemption Price Per Share
StockRedemptionPricePerShare
10.66
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001193125-24-076744-index-headers.html Edgar Link pending
0001193125-24-076744-index.html Edgar Link pending
0001193125-24-076744.txt Edgar Link pending
0001193125-24-076744-xbrl.zip Edgar Link pending
d68575d10k.htm Edgar Link pending
d68575dex311.htm Edgar Link pending
d68575dex312.htm Edgar Link pending
d68575dex321.htm Edgar Link pending
d68575dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d68575d10k_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wnnr-20231231.xsd Edgar Link pending
wnnr-20231231_def.xml Edgar Link unprocessable
wnnr-20231231_lab.xml Edgar Link unprocessable
wnnr-20231231_pre.xml Edgar Link unprocessable
wnnr-20231231_cal.xml Edgar Link unprocessable